About this trial
The purpose of this study is to assess if lenvatinib used with pembrolizumab are safe and effective in comparison to the best current available treatment.
Advanced endometrial cancer
Where’s this trial being run?Mater Misericordiae University Hospital
Can I join this study / trial?
The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.
Why not Print this page and bring it with you. It will help your doctor and research team advise you.Print this page
For more detailed informationClick Here
A Multicenter, Open-label, Randomized, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib in Combination with Pembrolizumab Versus Treatment of Physician’s Choice in Participants with Advanced Endometrial Cancer
|Principal Investigator:||Dr Austin Duffy (Mater Misericordiae University Hospital)|
Merck Sharp & Dohme Corp.
Global: June 2018
Ireland: October 2018
|Global Recruitment Target:||780|
|Ireland Recruitment Target:||5|